Relay Therapeutics (RLAY)
(Delayed Data from NSDQ)
$6.24 USD
-0.25 (-3.85%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $6.59 +0.35 (5.61%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.80 |
EPS Last Quarter | -0.69 |
Last EPS Surprise | 5.48% |
ABR | 1.17 |
Earnings ESP
|
-0.73% |
---|---|
Current Year | -2.91 |
Next Year | -3.12 |
EPS (TTM) | -2.52 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.35M | 0.35M | 10.35M | 3.45M |
# of Estimates | 2 | 2 | 5 | 2 |
High Estimate | 0.50M | 0.50M | 11.01M | 6.10M |
Low Estimate | 0.20M | 0.20M | 10.00M | 0.80M |
Year ago Sales | 25.20M | 0.00M | 25.55M | 10.35M |
Year over Year Growth Est. | -98.61% | NA | -59.50% | -66.65% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.80 | -0.73 | -2.91 | -3.12 |
# of Estimates | 8 | 7 | 8 | 9 |
Most Recent Consensus | -0.85 | -0.86 | -3.05 | -3.14 |
High Estimate | -0.73 | -0.38 | -2.83 | -2.85 |
Low Estimate | -0.85 | -0.86 | -3.05 | -3.44 |
Year ago EPS | -0.54 | -0.67 | -2.79 | -2.91 |
Year over Year Growth Est. | -48.15% | -8.96% | -4.30% | -7.13% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 2 |
Down Last 60 Days | 5 | 5 | 5 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.80 | -0.73 | -2.91 | -3.12 |
7 Days Ago | -0.80 | -0.73 | -2.91 | -3.07 |
30 Days Ago | -0.80 | -0.73 | -2.92 | -3.06 |
60 Days Ago | -0.73 | -0.66 | -2.83 | -2.82 |
90 Days Ago | -0.73 | -0.66 | -2.83 | -2.82 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.80 | -0.84 | -2.94 | -3.05 |
Zacks Consensus Estimate | -0.80 | -0.73 | -2.91 | -3.12 |
Earnings ESP | -0.73% | -15.06% | -0.94% | 2.32% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.69 | -0.62 | -0.67 | -0.54 | NA |
Estimate | -0.73 | -0.70 | -0.76 | -0.83 | NA |
Difference | 0.04 | 0.08 | 0.09 | 0.29 | 0.13 |
Surprise | 5.48% | 11.43% | 11.84% | 34.94% | 15.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more